---
title: "Viridian Therapeutics (VRDN.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/VRDN.US/norm.md"
symbol: "VRDN.US"
name: "Viridian Therapeutics"
parent: "https://longbridge.com/zh-CN/quote/VRDN.US.md"
datetime: "2026-06-13T21:06:37.173Z"
locales:
  - [en](https://longbridge.com/en/quote/VRDN.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/VRDN.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/VRDN.US/norm.md)
---

# Viridian Therapeutics (VRDN.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.9004 | -1.07 | -0.3444 | -1.00 | -0.8690 |
| ROE | -67.29% | -89.42% | -35.19% | -88.40% | -62.95% |
| 营业收入 | 141000.00 | 132000.00 | 70.57M | 75000.00 | 72000.00 |
| 净利润 | -92.03M | -101.07M | -28.17M | -81.98M | -70.69M |
| 营业利润 | -116.17M | -126.25M | -40.01M | -106.77M | -93.87M |
| 毛利率 | -50819.86% | -70133.33% | -22.23% | -115401.33% | -98631.94% |
| 净利率 | -74397.87% | -91178.03% | -49.03% | -134313.33% | -120711.11% |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 789.02M | 899.42M | 577.14M | 582.32M | 660.98M |
| 权益乘数 | 1.24 | 1.25 | 1.15 | 1.13 | 1.09 |
| 每股净资产 | 4.92 | 5.80 | 3.82 | 4.00 | 5.09 |
| 资产周转率 | 0.0978 | 0.0863 | 0.1049 | 0.0005 | 0.0005 |
| 现金及短投 | 762.18M | 874.65M | 490.90M | 563.36M | 636.63M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 3.38M | 3.65M | 3.71M | 3.07M | 3.25M |
| 净债务 | -708.83M | -822.06M | -466.70M | -540.27M | -613.53M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -119.65M | -23.75M | -84.61M | -75.37M | -92.65M |
| 投资现金流 | 77.26M | -339.42M | 126.08M | 75.72M | 100.06M |
| 融资现金流 | 6.36M | 405.91M | 10.86M | 764000.00 | 9.21M |
| 自由现金流 | -80.98M | 13.87M | -72.52M | -40.20M | -62.31M |
| 现金流充裕率 | -520234.78% | -9897.50% | -66622.83% | -179459.52% | -107736.05% |
| 举债与偿债 | - | 28.88M | - | - | - |
| 资本支出 | -23000.00 | -240000.00 | -127000.00 | -42000.00 | -86000.00 |